ArticleThe AAPS journal2024

Physiologically Based Biopharmaceutics Modeling for Gefapixant IR Formulation Development and Defining the Bioequivalence Dissolution Safe Space.

Michael Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.